ArticleBreast cancer research : BCR2023

Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer.

Menekse Göker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.